Group One Trading
EWTX icon

Group One Trading’s Edgewise Therapeutics EWTX Stock Holding History

Group One Trading’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
+4,477
New +$154K ﹤0.01% 4360
2025
Q2 		– Sell
-12,631
Closed -$182K – 8105
2025
Q1 		$278K Buy
12,631
+12,155
+2,554% +$319K ﹤0.01% 3685
2024
Q4 		$12.7K Buy
+476
New +$15.2K ﹤0.01% 5974
2023
Q3 		– Sell
-100
Closed -$775 – 7815
2023
Q2 		$775 Buy
+100
New +$843 ﹤0.01% 7312

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's EWTX Position: Q2 2026 in Review

Group One Trading opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 4,477 shares worth $182K. The stake represents ﹤0.01% of the portfolio and ranks #4360 among its holdings. This is a return to the name: Group One Trading previously reported a position in EWTX as recently as Q1 2025.

Group One Trading first reported a position in EWTX in Q2 2023 and has held it in 4 quarters since. The position peaked at $278K in Q1 2025. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Group One Trading held 4,477 shares of Edgewise Therapeutics worth $182K as of Q2 2026.
  • Edgewise Therapeutics was a new Group One Trading position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4360 holding.
  • Group One Trading first reported a position in Edgewise Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • Group One Trading's Edgewise Therapeutics position peaked at $278K in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.